|
7/01/20
|
BioMed Realty has obtained $165 mil in financing for 5300 Chiron Way, a 303.5k sf, Class A life science building in Emeryville. The building is located within BioMed Realty’s campus, known as the Emeryville Center of Innovation.
5300 Chiron Way, as part of a specialized hub for innovation, is 100% leased to Zymergen, a prominent science and material innovation company and one of the largest employers in Emeryville. The loan will allow BioMed Realty to invest capital to transform the asset into a specialized and innovative high-tech environment for Zymergen’s dynamic new headquarters location.
NKF’s Ramsey Daya and Chris Moritz of the Debt & Structured Finance team in the San Francisco office helped arrange the financing on behalf of the owner, BioMed Realty, a leading provider of real estate solutions to the life science and technology industries.
“Given BioMed’s reputation and track record, along with Zymergen’s cutting edge technology, lenders expressed significant interest in the financing,” said Daya. “The property presented an opportunity to help fund the development of what is the beginning of one of the most ground-breaking urban infill life science campuses on the West Coast. The lender stood out in a competitive landscape and was able to execute efficiently in a challenging environment.”
The investment market for life sciences real estate has developed over time, with institutional capital starting to actively pursue deals since 2010—now, institutional capital fully understands the prospects of the space and it is one of the most sought after, and discussed, investments, according to NKF’s 2020 Life Sciences: National Overview and Top Market Clusters report. Large and experienced landlords, such as BioMed Realty, continue to dominate the market share in San Francisco. With life sciences spanning 29.8 msf, the Bay Area market continues to be among the top urban clusters in the nation.
|
|
Return to the Archive page
|
|
|
|
|